EN
登录

细针穿刺细胞学对甲状腺癌症的诊断敏感性

Diagnostic sensitivity of fine-needle aspiration cytology in thyroid cancer

Nature 等信源发布 2024-10-16 14:09

可切换为仅中文


AbstractIntroduction Fine-needle aspiration cytology (FNAC) is an effective tool in the diagnostic work-up of patients with thyroid nodules. The aim of our study was to assess the diagnostic sensitivity of FNAC in thyroid cancer (TC) in Sweden by correlating the findings of preoperative FNAC with those obtained through final histology of the surgical specimen.

摘要简介细针穿刺细胞学(FNAC)是甲状腺结节患者诊断工作的有效工具。我们研究的目的是通过将术前FNAC的发现与通过手术标本的最终组织学获得的结果相关联,评估FNAC在瑞典甲状腺癌(TC)中的诊断敏感性。

Methods A Swedish nationwide cohort of patients having surgery for TC (n = 2519) from the Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal surgery between 2004 and 2013 was obtained. Data was validated through scrutinizing patient FNAC and histology reports. Results Among the 2519 cases operated with a final diagnosis of TC, the diagnosis was substantiated and validated through the histology report in 2332 cases (92.6%), included in the present study.

方法获得2004年至2013年间瑞典全国范围内甲状腺,甲状旁腺和肾上腺手术质量登记册中接受TC手术的患者队列(n=2519)。通过仔细检查患者FNAC和组织学报告来验证数据。结果在2519例最终诊断为TC的患者中,2332例(92.6%)通过组织学报告证实并验证了诊断。

Among these, 1679 patients (72%) were female and the median age at TC diagnosis was 52.3 years (range 18-94.6). In 353 cases (15.1%) FNAC was not performed at all; whereas in the remaining 1965 cases, the diagnostic sensitivity of FNAC was 81.6%. In lesions > 1 cm, FNAC diagnostic sensitivity reached 86.5%, whereas in lesions < 1 cm, FNAC yielded a sensitivity of 61.5%.

其中,1679名患者(72%)为女性,TC诊断的中位年龄为52.3岁(范围18-94.6)。在353例(15.1%)中,根本没有进行FNAC;而在其余1965例病例中,FNAC的诊断敏感性为81.6%。在病灶>1 cm时,FNAC诊断敏感性达到86.5%,而在病灶<1 cm时,FNAC的敏感性为61.5%。

Approximately 85% of FNACs (n = 1981/2332) were performed using ultra-sonographic (US) guidance. In TC lesions > 1 cm, the diagnostic sensitivity of US-guided FNAC (n = 1504) was 86.9% as compared to 76.9% in clinically applied FNAC without US utilization (n = 118). Conclusions FNAC is performed in most patients operated for TC in Sweden (85%) and retains its value as a tool in TC diagnostic work-up with an overall sensitivity of 82%, reaching 87% in lesions > 1 cm, that harbor clinically relevant TC..

大约85%的FNAC(1981/2332)是使用超声(US)指导进行的。在TC病变>1 cm时,美国引导的FNAC(n=1504)的诊断敏感性为86.9%,而在没有美国使用的临床应用FNAC中为76.9%(n=118)。结论FNAC在瑞典大多数接受TC手术的患者中进行(85%),并保留其作为TC诊断检查工具的价值,总体敏感性为82%,在具有临床相关TC的病变>1 cm时达到87%。。

IntroductionThyroid cancer (TC)is the most common endocrine malignancy and its incidence is rising at a rate 5–6% per year in the US, as well as internationally in analysis of population-level cancer registries world-wide1,2,3. Although the prognosis of well-differentiated TC (WDTC) cases, which constitute the majority of TCs (94–98%), is generally favorable, disease-specific mortality has been increasing at an average rate of 0.9% per year1,3.

。尽管构成TC大多数(94-98%)的高分化TC(WDTC)病例的预后通常是有利的,但疾病特异性死亡率每年平均以0.9%的速度增加1,3。

Despite that the observed increase in TC incidence appears to be coincident with early detection due to the widespread use of neck ultrasonography and fine-needle aspiration cytology (FNAC), this may not be the only reason for rising incidence rates, as this trend is observed across all different stages, among all ages, genders and ethnic groups4.Malignant follicular cell–derived neoplasms (FDTC) include papillary (PTC), follicular (FTC), and oncocytic (OTC) cell cancers that arise from follicular epithelial cells.

尽管由于颈部超声检查和细针穿刺细胞学检查(FNAC)的广泛使用,观察到的TC发病率增加似乎与早期发现相吻合,但这可能不是发病率上升的唯一原因,因为在所有不同阶段,在所有年龄,性别和种族中都观察到这种趋势。恶性滤泡细胞衍生肿瘤(FDTC)包括滤泡上皮细胞引起的乳头状(PTC),滤泡(FTC)和嗜酸细胞(OTC)细胞癌。

High-grade FDTC now includes both the traditional poorly differentiated carcinoma, as well as high-grade differentiated thyroid carcinomas since both are characterized by increased mitotic activity and tumor necrosis without anaplastic histology and clinically behave in a similar manner5. Anaplastic thyroid carcinoma (ATC) remains the most undifferentiated form with a dismal prognosis.

高级别FDTC现在既包括传统的低分化癌,也包括高级别分化的甲状腺癌,因为两者都以有丝分裂活性增加和肿瘤坏死为特征,没有间变性组织学,临床表现相似5。甲状腺未分化癌(ATC)仍然是最未分化的形式,预后不佳。

Medullary thyroid carcinoma (MTC) arises from parafollicular C-cells which produce calcitonin, and accounts for 5% of thyroid cancers, whereas less than 1–3% of TCs are ATC5,6,7.FNAC is one of the most useful methods for preoperative diagnosis of TC in clinical practice. A combined approach of neck ultrasound and FNAC comprise the main diagnostic workup of thyroid lesions.

甲状腺髓样癌(MTC)起源于产生降钙素的滤泡旁C细胞,占甲状腺癌的5%,而不到1-3%的TC是ATC5,6,7。FNAC是临床实践中术前诊断TC最有用的方法之一。颈部超声和FNAC的联合方法包括甲状腺病变的主要诊断检查。

In recent years, standardization of diagnostic terminology follow.

近年来,诊断术语的标准化随之而来。

Data availability

数据可用性

The registry data underlying this article will be shared upon reasonable request to the corresponding author.

本文的注册数据将在合理要求下共享给通讯作者。

ReferencesDavies, L. & Welch, H. G. Current thyroid cancer trends in the United States. JAMA Otolaryngol. Head Neck Surg. 140, 317–322. https://doi.org/10.1001/jamaoto.2014.1 (2014).Article

ReferencesDavies,L.&Welch,H.G。美国目前的甲状腺癌趋势。JAMA耳鼻喉科。头颈外科140317-322。https://doi.org/10.1001/jamaoto.2014.1(2014年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Kilfoy, B. A. et al. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control. 20, 525–531. https://doi.org/10.1007/s10552-008-9260-4 (2009).Article

Kilfoy,B.A.等人,《1973-2002年甲状腺癌发病率的国际模式和趋势》。癌症导致控制。20525-531。https://doi.org/10.1007/s10552-008-9260-4(2009年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Sipos, J. A. & Mazzaferri, E. L. Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. (R Coll. Radiol). 22, 395–404. https://doi.org/10.1016/j.clon.2010.05.004 (2010).Article

Sipos,J.A。&Mazzaferri,E.L。甲状腺癌流行病学和预后变量。临床。Oncol公司。(R Coll。Radiol)。22395-404。https://doi.org/10.1016/j.clon.2010.05.004(2010年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Aschebrook-Kilfoy, B., Kaplan, E. L., Chiu, B. C., Angelos, P. & Grogan, R. H. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann. Surg. Oncol. 20, 2746–2753. https://doi.org/10.1245/s10434-013-2892-y (2013).Article .

Aschebrook Kilfoy,B.,Kaplan,E.L.,Chiu,B.C.,Angelos,P。&Grogan,R.H。美国种族和族裔之间乳头状甲状腺癌发病率的加速相似。。202746-2753年。https://doi.org/10.1245/s10434-013-2892-y(2013年)。文章。

PubMed

PubMed

Google Scholar

谷歌学者

Baloch, Z. W. et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33, 27–63. https://doi.org/10.1007/s12022-022-09707-3 (2022).Article

Baloch,Z.W.等人,《2022年世界卫生组织甲状腺肿瘤分类概述》。内分泌。病理学。33,27-63。https://doi.org/10.1007/s12022-022-09707-3(2022年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Shah, J. P. Thyroid carcinoma: epidemiology, histology, and diagnosis. Clin. Adv. Hematol. Oncol. 13, 3–6 (2015).PubMed

Shah,J.P。甲状腺癌:流行病学,组织学和诊断。临床。高级血液学。Oncol公司。13,3-6(2015)。PubMed出版社

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30. https://doi.org/10.3322/caac.21166 (2013).Article

Siegel,R.,Naishadham,D。和Jemal,A。癌症统计,2013年。CA Cancer J.Clin。63,11-30。https://doi.org/10.3322/caac.21166(2013年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Cibas, E. S., Ali, S. Z., Conference, N. C. & I. T. F. S. o. t. S. The Bethesda system For reporting thyroid cytopathology. Am. J. Clin. Pathol. 132, 658–665 https://doi.org/10.1309/AJCPPHLWMI3JV4LA (2009).Pusztaszeri, M. et al. The Bethesda System for reporting thyroid cytopathology: proposed modifications and updates for the Second Edition from an International Panel.

Cibas,E.S.,Ali,S.Z.,Conference,N.C.&I.T.F.S.o.T.S.贝塞斯达甲状腺细胞病理学报告系统。美国J.克林。病理学。132658-665https://doi.org/10.1309/AJCPPHLWMI3JV4LA(2009年)。。

Acta Cytol. 60, 399–405. https://doi.org/10.1159/000451020 (2016).Article .

Acta Cytol. 60, 399–405. https://doi.org/10.1159/000451020 (2016).Article .

PubMed

PubMed

Google Scholar

谷歌学者

Ho, A. S. et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid. 24, 832–839. https://doi.org/10.1089/thy.2013.0317 (2014).Article

Ho,A.S.等人。分类为贝塞斯达III类(AUS/FLUS)的甲状腺结节的恶性率。甲状腺。24832-839。https://doi.org/10.1089/thy.2013.0317(2014年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Bongiovanni, M., Spitale, A., Faquin, W. C., Mazzucchelli, L. & Baloch, Z. W. The Bethesda System for reporting thyroid cytopathology: a meta-analysis. Acta Cytol. 56, 333–339. https://doi.org/10.1159/000339959 (2012).Article

Bongiovanni,M.,Spitale,A.,Fakuin,W.C.,Mazzucchelli,L。&Baloch,Z.W。贝塞斯达甲状腺细胞病理学报告系统:荟萃分析。细胞学报。56333-339。https://doi.org/10.1159/000339959(2012年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Padmanabhan, V. et al. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: a study of interobserver variability among cytopathologists.

Padmanabhan,V。等人。当审查来自不同机构的载玻片时,使用bethesda系统报告甲状腺细胞学时,未确定意义的异型性/未确定意义类别的滤泡病变的可重复性:细胞病理学家之间观察者间变异性的研究。

Diagn. Cytopathol. 45, 399–405. https://doi.org/10.1002/dc.23681 (2017).Article .

。细胞病理学。45399-405。https://doi.org/10.1002/dc.23681(2017年)。文章。

PubMed

PubMed

Google Scholar

谷歌学者

Ali, S. Z. et al. The 2023 Bethesda System for reporting thyroid cytopathology. Thyroid. 33, 1039–1044. https://doi.org/10.1089/thy.2023.0141 (2023).Article

Ali,S.Z.等人,《2023年贝塞斯达甲状腺细胞病理学报告系统》。甲状腺。33039-1044年。https://doi.org/10.1089/thy.2023.0141(2023年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Kuru, B., Gulcelik, N. E., Gulcelik, M. A. & Dincer, H. The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules. Langenbecks Arch. Surg. 395, 127–132. https://doi.org/10.1007/s00423-009-0470-3 (2010).Article

Kuru,B.,Gulcelik,N.E.,Gulcelik,M.A。和Dincer,H。细针穿刺细胞学诊断甲状腺结节中甲状腺癌的假阴性率。Langenbecks拱门。外科395127-132。https://doi.org/10.1007/s00423-009-0470-3(2010年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Porterfield, J. R. Jr. et al. Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery. 144, 963–968. https://doi.org/10.1016/j.surg.2008.09.006 (2008). discussion 968–969.Article

Porterfield,J.R.Jr.等。甲状腺大结节良性细针穿刺细胞学检查的可靠性。手术。144963-968年。https://doi.org/10.1016/j.surg.2008.09.006(2008年)。讨论968–969.文章

PubMed

PubMed

Google Scholar

谷歌学者

McHenry, C. R., Huh, E. S. & Machekano, R. N. Is nodule size an independent predictor of thyroid malignancy? Surgery. 144, 1062–1068. https://doi.org/10.1016/j.surg.2008.07.021 (2008). discussion 1068–1069.Article

McHenry,C.R.,Huh,E.S。&Machekano,R.N。结节大小是甲状腺恶性肿瘤的独立预测因子吗?手术。1441062-1068年。https://doi.org/10.1016/j.surg.2008.07.021(2008年)。讨论1068–1069.文章

PubMed

PubMed

Google Scholar

谷歌学者

Frates, M. C. et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J. Clin. Endocrinol. Metab. 91, 3411–3417. https://doi.org/10.1210/jc.2006-0690 (2006).Article

Frates,M.C.等人。超声检查甲状腺单发结节和多发结节患者的癌症患病率和分布。J、 临床。内分泌。代谢。913411-3417。https://doi.org/10.1210/jc.2006-0690(2006年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Shrestha, M., Crothers, B. A. & Burch, H. B. The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: a 10-year study from a single institution. Thyroid. 22, 1251–1256. https://doi.org/10.1089/thy.2012.0265 (2012).Article

。甲状腺。221251-1256年。https://doi.org/10.1089/thy.2012.0265(2012年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Staibano, P. et al. Ultrasonography and Fine-Needle aspiration in indeterminate thyroid nodules: a systematic review of Diagnostic Test Accuracy. Laryngoscope. 132, 242–251. https://doi.org/10.1002/lary.29778 (2022).Article

Staibano,P。等。不确定甲状腺结节的超声检查和细针穿刺:诊断测试准确性的系统评价。喉镜。132242-251。https://doi.org/10.1002/lary.29778(2022年)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Tarigan, T. J. E., Anwar, B. S., Sinto, R. & Wisnu, W. Diagnostic accuracy of palpation versus ultrasound-guided fine needle aspiration biopsy for diagnosis of malignancy in thyroid nodules: a systematic review and meta-analysis. BMC Endocr. Disord. 22, 181. https://doi.org/10.1186/s12902-022-01085-5 (2022).Article .

Tarigan,T。J。E.,Anwar,B。S.,Sinto,R。&Wisnu,W。触诊与超声引导下细针穿刺活检诊断甲状腺结节恶性肿瘤的诊断准确性:系统评价和荟萃分析。BMC内分泌。混乱。。https://doi.org/10.1186/s12902-022-01085-5(2022年)。文章。

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Lim, H., Devesa, S. S., Sosa, J. A., Check, D. & Kitahara, C. M. Trends in thyroid Cancer incidence and mortality in the United States, 1974–2013. JAMA. 317, 1338–1348. https://doi.org/10.1001/jama.2017.2719 (2017).Article

Lim,H.,Devesa,S.S.,Sosa,J.A.,Check,D。和Kitahara,C.M。1974-2013年美国甲状腺癌发病率和死亡率的趋势。杰玛。3171338-1348年。https://doi.org/10.1001/jama.2017.2719(2017年)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Haugen, B. R. et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1-133 https://doi.org/10.1089/thy.2015.0020 (2016).Force, U.

Haugen,B.R.等人,《美国甲状腺协会成人甲状腺结节和分化型甲状腺癌患者管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组》。甲状腺26,1-133https://doi.org/10.1089/thy.2015.0020。武力,美国。

S. P. S. T. et al. Screening for thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 317, 1882–1887. https://doi.org/10.1001/jama.2017.4011 (2017).Article .

S、 P.S.T.等人,《甲状腺癌筛查:美国预防服务工作组建议声明》。杰玛。3171882-1887年。https://doi.org/10.1001/jama.2017.4011(2017年)。文章。

Google Scholar

谷歌学者

Download referencesFundingOpen access funding provided by Örebro University. The authors of the study have not received any funding.Author informationAuthors and AffiliationsAnesthesiology Department, Skellefteå Hospital, Skellefteå, SwedenPatrik LindDepartment of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, 70185, SwedenPatrik Lind, Anton Jacobson, Göran Wallin & Kosmas DaskalakisDepartment of Surgery, Skåne University Hospital, Lund, SwedenErik NordenströmDepartment of Clinical Sciences, Lund University, Lund, SwedenErik NordenströmDepartment of Public Health and Clinical Medicine, Skellefteå Research Unit, Umeå University, Umeå, SE-901 81, SwedenLars JohanssonSecond Department of Surgery, Korgialenio-Benakio, Red Cross General Hospital, Athanasaki 11, Athens, 11526, GreeceKosmas DaskalakisAuthorsPatrik LindView author publicationsYou can also search for this author in.

下载由Örebro大学提供的参考基金开放获取资金。该研究的作者尚未获得任何资金。作者信息作者和附属机构Skellefteå医院感觉科,Skellefteå,SwedenPatrik Lind外科,医学与健康学院,Örebro,70185,SwedenPatrik Lind,Anton Jacobson,Göran Wallin&Kosmas Daskalakis外科,Skellefteåne大学医院,隆德,SwedenErik Nordenström隆德大学临床科学系,隆德,SwedenErik Nordenström公共卫生与临床医学系,Skellefteå229乌梅大学研究室,乌梅,SE-901 81,斯威登拉尔斯·约翰逊第二外科,Korgialenio Benakio,红十字会总医院,Athanasaki 11,雅典,11526,GreeceKosmas Daskalakis作者Patrik LindView作者出版物你也可以在中搜索这位作者。

PubMed Google ScholarAnton JacobsonView author publicationsYou can also search for this author in

PubMed Google ScholarAnton JacobsonView作者出版物您也可以在

PubMed Google ScholarErik NordenströmView author publicationsYou can also search for this author in

PubMed Google ScholarErik NordenströmView作者出版物您也可以在

PubMed Google ScholarLars JohanssonView author publicationsYou can also search for this author in

PubMed谷歌学者JohanssonView作者出版物您也可以在

PubMed Google ScholarGöran WallinView author publicationsYou can also search for this author in

PubMed Google ScholarGöran WallinView作者出版物您也可以在

PubMed Google ScholarKosmas DaskalakisView author publicationsYou can also search for this author in

PubMed Google ScholarKosmas DaskalakisView作者出版物您也可以在

PubMed Google ScholarContributionsK.D. and G.W. conceived and designed the study. P.L., A.J. and K.D. collected the data, performed analyses, and drafted the manuscript. E.N.,L.J., G.W. and K.D. provided supervision and administrative support. All authors approved the final manuscript text.Corresponding authorCorrespondence to.

PubMed谷歌学术贡献SK。D、 和G.W.构思并设计了这项研究。P、 L.,A.J.和K.D.收集了数据,进行了分析,并起草了手稿。E、 N.,L.J.,G.W.和K.D.提供了监督和行政支持。所有作者都批准了最终稿件文本。对应作者对应。

Kosmas Daskalakis.Ethics declarations

Kosmas Daskalakis公司。道德宣言

Competing interests

相互竞争的利益

The authors declare no competing interests.

Additional informationPublisher’s noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Electronic supplementary materialBelow is the link to the electronic supplementary material.Supplementary Material 1Supplementary Material 2Rights and permissions.

Additional informationPublisher的noteSpringer Nature在已发布地图和机构隶属关系中的管辖权主张方面保持中立。电子补充材料流是指向电子补充材料的链接。补充材料1补充材料2权利和许可。

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

开放获取本文是根据知识共享署名4.0国际许可证授权的,该许可证允许以任何媒体或格式使用,共享,改编,分发和复制,只要您对原始作者和来源给予适当的信任,提供知识共享许可证的链接,并指出是否进行了更改。

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

本文中的图像或其他第三方材料包含在文章的知识共享许可中,除非在材料的信用额度中另有说明。如果材料未包含在文章的知识共享许可证中,并且您的预期用途未被法律法规允许或超出允许的用途,则您需要直接获得版权所有者的许可。

To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/..

要查看此许可证的副本,请访问http://creativecommons.org/licenses/by/4.0/..

Reprints and permissionsAbout this articleCite this articleLind, P., Jacobson, A., Nordenström, E. et al. Diagnostic sensitivity of fine-needle aspiration cytology in thyroid cancer.

转载和许可本文引用本文Lind,P.,Jacobson,A.,Nordenström,E。等人。甲状腺癌细针穿刺细胞学的诊断敏感性。

Sci Rep 14, 24216 (2024). https://doi.org/10.1038/s41598-024-75677-7Download citationReceived: 25 May 2024Accepted: 07 October 2024Published: 16 October 2024DOI: https://doi.org/10.1038/s41598-024-75677-7Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

科学报告1424216(2024)。https://doi.org/10.1038/s41598-024-75677-7Download引文收到日期:2024年5月25日接受日期:2024年10月7日发布日期:2024年10月16日OI:https://doi.org/10.1038/s41598-024-75677-7Share本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供

KeywordsDiagnostic sensitivityFine-needle aspiration cytologyThyroid cancer

关键词细针穿刺细胞学甲状腺癌的诊断敏感性